Calumet Spec. Prods Part. ADR Logo
US1314761032
A0H1BP
CLMT

Calumet Spec. Prods Part. ADR

Kurser indlæses...

Prognose

Analytikernes gennemsnitlige kursmål er 54,23 € (+88,36 %). Medianen er 51,80 € (+79,92 %).

Køb
  4
Behold
  18
Sælg
  1

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • Calumet misses Q1 2026 earnings forecasts despite progress in renewable fuels

    Calumet reported Q1 2026 earnings per share of -$3.64, missing analysts’ expectation of -$0.31, while revenue of $1.03 billion slightly exceeded estimates. A production outage in Shreveport due to organic chloride contamination cost about 750,000 barrels and roughly $30 million, which pushed adjusted EBITDA down to $50.1 million. Montana Renewables showed strong operational improvements (adjusted EBITDA +209%) and the MaxSAF-150 expansion began operations, while the new SET-2 RVO has significantly increased demand for biofuels and improved margins. Management expects that the resumption of production and a better market environment will lead to improved results in 2026, but continues to see challenges with the debt structure. » Mere på de.investing.com


  • Calumet announces quarterly results for 31 March 2026, analysts see significantly smaller loss

    Calumet expects to release results for the quarter ended 31 March 2026 on 8 May 2026. Five analysts on average expect earnings per share of -$0.333 versus -$1.870 in the year‑ago quarter. Six analysts forecast revenue of around $1.01 billion (+1.93% year‑on‑year). For the current fiscal year the consensus estimate is $0.077 per share and revenue of about $4.41 billion. » Mere på finanzen.net


  • Calumet: supervisory board member Jennifer Straumins will not stand for re-election in 2026

    Jennifer Straumins will not stand for re-election to Calumet’s supervisory board at the annual general meeting in 2026 and will leave the board at the end of her term. Straumins has been a member of the supervisory board since July 2024; she was previously a member of the board of Calumet GP, LLC and worked for the company for 13 years. She currently serves on the strategy and growth committee and the risk committee; the supervisory board now intends to review the composition and competencies of the body. » Mere på de.investing.com


  • Calumet cuts debt by $220 million, Q4 profitability remains weak

    Calumet reported adjusted EBITDA of $293.3 million for 2025 and highlighted a reduction in restricted liabilities of more than $220 million. Despite cost cuts and higher production, the company missed Q4 estimates by a wide margin; diluted EPS was -$0.43 versus -$0.22 expected. The Specialty Products segment showed strong margins, while Montana Renewables was weighed down by low industry margins and transaction costs. Management emphasizes debt reduction, cash-flow improvement and the MaxSAF150 project (completion Q2 2026) as key levers to restore profitability. » Mere på de.investing.com


  • S&P raises outlook for Calumet to positive after refinancing

    S&P Global Ratings has raised the outlook for Calumet from "stable" to "positive" and affirmed the rating at CCC+ after the company refinanced short-term liabilities by issuing unsecured bonds and extended the ABL maturity. S&P expects improvements in credit metrics over the next 12 months, with EBITDA margins projected to rise by about 200 basis points to roughly 8% in 2025 and to approach the 10% mark in 2026/27. Calumet’s subsidiary Montana Renewables plans to increase SAF capacity in Q2 2026 to 120–150 million gallons, and contracts already signed cover much of the expansion. Risks remain from commodity price and regulatory exposure and possible RIN-related obligations that could strain liquidity and metrics. » Mere på de.investing.com

I 2006 har Calumet Spec. Prods Part. ADR allerede udloddet 0,23 € i udbytte. Den seneste udlodning fandt sted i maj 2006.

Virksomhedstal

I det seneste kvartal havde Calumet Spec. Prods Part. ADR en omsætning på 1,49 mia. € og et nettoresultat på 226,36 mio. €
(EUR) september 2026
YoY
Omsætning 1,49 mia. 61,74 %
Bruttofortjeneste 479,56 mio. 50,60 %
Nettoresultat 226,36 mio. 15,24 %
EBITDA 293,72 mio. 0,09 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
2,59 mia. €
Antal aktier
88,09 mio.
Højeste/laveste i 52 uger
54,41 € - 16,22 €
Udbytte Nej
Beta
0,78
P/E (PE Ratio)
-14,37
PEG (PEG Ratio)
0,04
K/I (PB Ratio)
-3,27
P/S (PS Ratio)
0,55

Virksomhedsprofil

Calumet Specialty Products Partners, L.P. fremstiller, formulerer og markedsfører et sortiment af specialiserede mærkeprodukter til forskellige forbrugerrettede og industrielle markeder i Nordamerika og internationalt. Dets segment for specialprodukter og -løsninger tilbyder forskellige opløsningsmidler, voks, tilpassede smøreolier, hvidolier, petrolatum, geler, estere og andre produkter. Virksomhedens segment Montana/Renewables fokuserer på at forarbejde vedvarende råmaterialer til vedvarende brint, vedvarende naturgas, vedvarende propan, vedvarende nafta, vedvarende petroleum/flybrændstof og vedvarende diesel. Segmentet forarbejder også canadisk råolie til konventionel benzin, diesel, jetbrændstof og specialkvaliteter af asfalt. Dets segment Performance Brands blender, pakker og markedsfører højtydende produkter under mærkerne Royal Purple, Bel-Ray og TruFuel. Calumet GP, LLC fungerer som komplementar for Calumet Specialty Products Partners, L.P. Virksomheden blev grundlagt i 1916 og har hovedkvarter i Indianapolis, Indiana.

Navn
Calumet Spec. Prods Part. ADR
CEO
Louis Todd Borgmann
Hjemsted Indianapolis, in
USA
Websted
Sektor
Energi
Branche
Olie, gas og ikke-vedvarende brændstoffer
Børsnotering
26.01.2006
Medarbejdere 1.540

Tickersymboler

Børs Symbol
NASDAQ
CLMT
🍪

Parqet  bruger cookies. Læs mere